Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain

Summary

* The primary objectives of this placebo-controlled clinical trial are to evaluate the analgesic efficacy and safety of bicifadine 200 mg BID compared with placebo in patients with moderate to severe chronic low back pain. * The secondary objectives are to evaluate the effect of bicifadine on function and general quality of life, to evaluate safety following discontinuation of bicifadine treatment and to investigate the population pharmacokinetics of bicifadine.

Timeline

Start

2005-10

Primary completion

—

Completion

—

Drugs

Indications